Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

NCT01442519 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: bacillus Calmette-Guerin
DRUG: electromotive mitomycin

Sponsor

University of Rome Tor Vergata

Collaborators

[object Object]